High Grade Hepatotoxicity From Dual Checkpoint Inhibitors Is More Common in Hepatocellular Carcinoma Than Other Cancers

By afschroeder • August 9, 2025

Ennin E, Mallepally N, Ali M, Shojaie L, Dewberry S, Trieu M, Torres ETR, Zhou K, Kahn J, Dodge JL, Dara L. High Grade Hepatotoxicity From Dual Checkpoint Inhibitors Is More Common in Hepatocellular Carcinoma Than Other Cancers. Liver Int. 2025 Sep;45(9):e70255. doi: 10.1111/liv.70255. PMID: 40778804.

Tags: CTLA‐4, Digestive Diseases, Fellow, ILICI, immune‐related adverse events, immunotherapy, liver injury, PD‐1, Publications

IBS stress reactivity phenotype is associated with blood transcriptome profiles and microstructural and functional brain changes

Labus JS, Delgadillo DR, Cole S, Wang C, Joshi S, Church A, Naliboff B, Chang L, Jacobs JP, Ellingson BM, Mayer EA. IBS stress reactivity[...]

Pancreatic solid pseudopapillary neoplasm mimicking a pseudocyst in a young female with acute pancreatitis

Litwin S, Yang SK, Jen HC, Sedarat A, Chan AP. Pancreatic solid pseudopapillary neoplasm mimicking a pseudocyst in a young female with acute pancreatitis. JPGN[...]

Single-cell and spatial omics in liver identify cell-cell communication regulators in aging and insulin resistance

Zhao W, Jiao X, Du K, Sun Q, Duan J, Cao Y, Shen X, Said Z, Karri SS, Ellsworth P, Hu W, Sargsyan A, Astapova[...]